Head and Neck
Multidisciplinary management of head and neck cancers is essential to both understanding current treatment paradigms and tailoring treatment to the individual patient. Part of optimizing care is to understand how to intensify treatment in unfavorable cases while deescalating therapy in low risk cohorts. Numerous approaches testing different combinations of treatment modalities are under investigation. It is difficult to stay informed about what is standard of care or under active study. Additionally, understanding strategies to minimize radiation therapy toxicity play a critical factor in maintaining quality of life and organ function preservation.
The activity is designed to meet the interests of practicing radiation oncologists, radiation oncology residents, medical and clinical physicists, nurses and all other health professionals involved in the field of radiation oncology.
Upon completion of this live activity, attendees should be able to do the following:
1. Describe how to minimize toxicity with improved understanding of OAR and tumor contouring.
2. Discuss the need for incorporating other treatment modalities with RT to optimize oncologic outcomes.
3. Outline current treatment paradigms and future clinical research directions.
Kenneth Shung Hu, MD, FASTRO, is employed by and has stock in Amgen, Bioden Idec, and Johnson and Johnson
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.50 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.50 Certificate of AttendanceThis activity was designated for 1.50 AMA PRA Category 1 Credit™.